These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23694952)

  • 41. Critical, but conditional, role of OX40 in memory T cell-mediated rejection.
    Vu MD; Clarkson MR; Yagita H; Turka LA; Sayegh MH; Li XC
    J Immunol; 2006 Feb; 176(3):1394-401. PubMed ID: 16424166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection.
    Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Yagita H; Turka LA; Sayegh MH
    Am J Transplant; 2005 Jan; 5(1):31-9. PubMed ID: 15636609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Vallera DA
    Blood; 1995 May; 85(9):2607-18. PubMed ID: 7537122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early Notch Signals Induce a Pathogenic Molecular Signature during Priming of Alloantigen-Specific Conventional CD4
    Chung J; Radojcic V; Perkey E; Parnell TJ; Niknafs Y; Jin X; Friedman A; Labrecque N; Blazar BR; Brennan TV; Siebel CW; Maillard I
    J Immunol; 2019 Jul; 203(2):557-568. PubMed ID: 31182480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.
    Foster AD; Haas M; Puliaeva I; Soloviova K; Puliaev R; Via CS
    Clin Immunol; 2010 Jul; 136(1):61-73. PubMed ID: 20451460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Only therapeutic ICOS:ICOSL blockade alleviates acute graft versus host disease.
    Mollweide A; Staege MS; Hoeschen C; Hideo Y; Burdach S; Richter GH
    Klin Padiatr; 2009; 221(6):344-50. PubMed ID: 19890785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Critical role of OX40 in CD28 and CD154-independent rejection.
    Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
    J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
    Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
    Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma.
    Fowler DH; Gress RE
    Leuk Lymphoma; 2000 Jul; 38(3-4):221-34. PubMed ID: 10830730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Canine Model of Chronic Graft-versus-Host Disease.
    Graves SS; Rezvani A; Sale G; Stone D; Parker M; Rosinski S; Spector M; Swearingen B; Kean L; Storb R
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):420-427. PubMed ID: 28013013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naïve CD4+ T cells.
    Mesturini R; Nicola S; Chiocchetti A; Bernardone IS; Castelli L; Bensi T; Ferretti M; Comi C; Dong C; Rojo JM; Yagi J; Dianzani U
    Eur J Immunol; 2006 Oct; 36(10):2601-12. PubMed ID: 17013990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ICOS/B7RP-1 interference in mouse kidney transplantation.
    Lutz J; Lu R; Strobl M; Huang H; Deng M; Wang M; Ouyang N; Heemann U
    Transplantation; 2007 Jul; 84(2):223-30. PubMed ID: 17667814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory roles of IL-2 and IL-4 in H4/inducible costimulator expression on activated CD4+ T cells during Th cell development.
    Yagi J; Arimura Y; Dianzani U; Uede T; Okamoto T; Uchiyama T
    J Immunol; 2003 Jul; 171(2):783-94. PubMed ID: 12847246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.
    Shenoy S; Desch K; Duffy B; Thorson P; Mohanakumar T
    Clin Exp Immunol; 1998 May; 112(2):188-95. PubMed ID: 9649180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
    Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease.
    Hartmann N; Leithäuser F; Albers C; Duyster J; Möller P; Debatin KM; Strauss G
    Leukemia; 2011 May; 25(5):848-55. PubMed ID: 21331071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Further study of anti-ICOS immunotherapy for rat cardiac allograft rejection.
    Pan XC; Guo L; Deng YB; Naruse K; Kimura H; Sugawara Y; Makuuchi M
    Surg Today; 2008; 38(9):815-25. PubMed ID: 18751947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
    Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-cell co-signalling molecules in graft-versus-host disease.
    Tanaka J; Asaka M; Imamura M
    Ann Hematol; 2000 Jun; 79(6):283-90. PubMed ID: 10901605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.